Revenue | ₹602.70Cr |
Net Profits | ₹130.03Cr |
Net Profit Margins | 21.57% |
Alivus Life Sciences Ltd’s revenue jumped 16.94% since last year same period to ₹602.70Cr in the Q2 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated -1.33% fall in its revenue since last 3-months.
Alivus Life Sciences Ltd’s net profit jumped 36.41% since last year same period to ₹130.03Cr in the Q2 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 6.99% jump in its net profits since last 3-months.
Alivus Life Sciences Ltd’s net profit margin jumped 16.66% since last year same period to 21.57% in the Q2 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 8.43% jumped in its net profit margins since last 3-months.
The revenue for Alivus Life Sciences Ltd in the Q2 results 2025 was ₹602.70Cr.
The net profit for Alivus Life Sciences Ltd in the Q2 results 2025 was ₹130.03Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q2 results 2025 was 21.57%.
The revenue for Alivus Life Sciences Ltd in the Q2 results 2024 was ₹515.41Cr.
The net profit for Alivus Life Sciences Ltd in the Q2 results 2024 was ₹95.32Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q2 results 2024 was 18.49%.